What Causes Benign Prostatic Hyperplasia?
Benign prostatic hyperplasia (BPH) is a multifactorial disease of unknown exact etiology that requires testosterone and develops from an imbalance between cellular growth and apoptosis (programmed cell death) in the prostatic transition zone, favoring excessive cellular proliferation. 1
Essential Hormonal Mechanism
The development of BPH fundamentally depends on androgens, though testosterone itself is not the direct etiological trigger 1, 2:
- 5α-reductase enzymes (type I and II) convert testosterone to dihydrotestosterone (DHT), which has higher affinity for androgen receptors and is the more potent androgenic hormone 1, 3
- The testosterone/DHT-androgen receptor complex transports to the cell nucleus, initiating DNA transcription and translation
- This process leads to proliferation of glandular epithelial tissue, smooth muscle, and connective tissue specifically within the prostatic transition zone 1
- Critical distinction: While testosterone is required for BPH development, there is no evidence that testosterone or DHT initiates BPH 2—rather, intraprostatic DHT promotes BPH progression after cellular damage has occurred
Age as the Primary Risk Factor
BPH is nearly ubiquitous in aging males 1:
- Increases begin at age 40-45 years
- Reaches 60% prevalence by age 60
- Affects 80% of men by age 80
Emerging Etiological Theories
Recent research suggests a more complex pathogenesis 2, 4, 3:
The Urinary Toxin Hypothesis
- Since BPH occurs exclusively in the transitional zone surrounding the urethra, prolonged exposure to uncharacterized urinary toxins may disrupt stromal and epithelial homeostasis 2
- This chronic exposure, typical in aging men, causes cellular damage and subsequent inflammation
- After this initial damage, intraprostatic DHT drives nodular proliferation
Contributing Factors
Beyond hormones and aging, multiple factors contribute 5, 4, 3:
- Metabolic factors: Obesity, type 2 diabetes, metabolic syndrome
- Chronic inflammation: Increasingly recognized as central to BPE and LUTS development
- Lifestyle factors: Physical inactivity, high alcohol consumption
- Genetic predisposition: Family history of BPH
- Racial/ethnic factors: Higher risk in Black and Hispanic men 5
- Growth factors and epithelial-stromal interactions 4
- Estrogens: May participate in nodular stromal cell proliferation in some patients 2
The Growth-Apoptosis Imbalance
The fundamental cellular mechanism is an imbalance favoring growth over apoptosis, resulting in increased cellular mass 1. This is not simply excessive growth, but rather a failure of normal programmed cell death to counterbalance ongoing cellular proliferation.
Clinical Implications
Understanding causation clarifies why:
- 5α-reductase inhibitors (finasteride, dutasteride) work by blocking DHT production, addressing the hormonal driver of progression 3
- BPH cannot develop in men without functional testosterone
- Age and metabolic health are non-modifiable and modifiable risk factors respectively
- The disease is progressive in nature, with symptoms worsening over time in untreated patients 6, 1